{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:30:36Z","timestamp":1791304236680,"version":"4.3.1"},"reference-count":100,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T00:00:00Z","timestamp":1613347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The picture of chronic liver diseases (CLDs) has changed considerably in recent years. One of them is the increase of non-alcoholic fatty liver disease. More and more CLD patients, even those with liver cirrhosis (LC), tend to be presenting with obesity these days. The annual rate of muscle loss increases with worsening liver reserve, and thus LC patients are more likely to complicate with sarcopenia. LC is also characterized by protein-energy malnutrition (PEM). Since the PEM in LC can be invariable, the patients probably present with sarcopenic obesity (Sa-O), which involves both sarcopenia and obesity. Currently, there is no mention of Sa-O in the guidelines; however, the rapidly increasing prevalence and poorer clinical consequences of Sa-O are recognized as an important public health problem, and the diagnostic value of Sa-O is expected to increase in the future. Sa-O involves a complex interplay of physiological mechanisms, including increased inflammatory cytokines, oxidative stress, insulin resistance, hormonal disorders, and decline of physical activity. The pathogenesis of Sa-O in LC is diverse, with a lot of perturbations in the muscle\u2013liver\u2013adipose tissue axis. Here, we overview the current knowledge of Sa-O, especially focusing on LC.<\/jats:p>","DOI":"10.3390\/ijms22041917","type":"journal-article","created":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T03:22:26Z","timestamp":1613359346000},"page":"1917","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Sarcopenic Obesity in Liver Cirrhosis: Possible Mechanism and Clinical Impact"],"prefix":"10.3390","volume":"22","author":[{"given":"Hiroki","family":"Nishikawa","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Gastroenterology and Hepatology, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan"},{"name":"Center for Clinical Research and Education, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirayuki","family":"Enomoto","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Gastroenterology and Hepatology, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Nishiguchi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kano General Hospital, Osaka 531-0041, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Iijima","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Gastroenterology and Hepatology, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1007\/s00330-019-06573-2","article-title":"Imaging of sarcopenia: Old evidence and new insights","volume":"30","author":"Albano","year":"2020","journal-title":"Eur. Radiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/ajcn\/50.5.1231","article-title":"Summary comments: Epidemiological and methodological problems in determining nutritional status of older persons","volume":"50","author":"Rosenberg","year":"1989","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_3","first-page":"16","article-title":"Writing group for the european working group on sarcopenia in older people 2 (EWGSOP2), and the extended group for EWGSOP2. Sarcopenia: Revised European consensus on definition and diagnosis","volume":"48","author":"Bahat","year":"2019","journal-title":"Age Ageing."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","article-title":"Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment","volume":"21","author":"Chen","year":"2020","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Nishikawa, H., Enomoto, H., Nishiguchi, S., and Iijima, H. (2020). Liver cirrhosis and sarcopenia from the viewpoint of dysbiosis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21155254"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.bbrc.2003.07.016","article-title":"Branched-chain amino acids as a protein- and energy-source in liver cirrhosis","volume":"313","author":"Moriwaki","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_7","first-page":"105","article-title":"Branched-chain amino acid-enriched supplementation improves insulin resistance in patients with chronic liver disease","volume":"22","author":"Kawaguchi","year":"2008","journal-title":"Int. J. Mol. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s13539-012-0069-3","article-title":"Consilience in sarcopenia of cirrhosis","volume":"3","author":"Dasarathy","year":"2012","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/hepr.12616","article-title":"Rapid skeletal muscle wasting predicts worse survival in patients with liver cirrhosis","volume":"46","author":"Hanai","year":"2016","journal-title":"Hepatol. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1749-6632.2000.tb06498.x","article-title":"Body composition in healthy aging","volume":"904","author":"Baumgartner","year":"2000","journal-title":"Ann. NY Acad. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1017\/S002966511500169X","article-title":"Muscle loss and obesity: The health implications of sarcopenia and sarcopenic obesity","volume":"74","author":"Wannamethee","year":"2015","journal-title":"Proc. Nutr. Soc."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-\u20132019: A systematic review and meta-analysis","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_13","unstructured":"World Health Organization (WHO) (2017). Obesity and Overweight Factsheet from the WHO, World Health Organization."},{"key":"ref_14","unstructured":"(2000). The Asia-Pacific Perspective: Redefining Obesity and its Treatment, Word Health Organisation."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1097\/TP.0000000000001794","article-title":"Liver transplantation in the obese cirrhotic patient","volume":"101","author":"Spengler","year":"2017","journal-title":"Transplantation"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1111\/liv.13137","article-title":"Obesity paradox in advanced liver disease: Obesity is associated with lower mortality in hospitalized patients with cirrhosis","volume":"36","author":"Karagozian","year":"2016","journal-title":"Liver Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.4254\/wjh.v7.i28.2819","article-title":"Treating morbid obesity in cirrhosis: A quest of holy grail","volume":"7","author":"Kumar","year":"2015","journal-title":"World J. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/jcb.25077","article-title":"The implications of sarcopenia and sarcopenic obesity on cardiometabolic disease","volume":"116","author":"Kim","year":"2015","journal-title":"J. Cell Biochem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.numecd.2007.10.002","article-title":"Sarcopenic obesity: A new category of obesity in the elderly","volume":"18","author":"Zamboni","year":"2008","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/jcsm.12039","article-title":"Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis","volume":"7","author":"Angulo","year":"2016","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s11605-015-2838-8","article-title":"Effect of intramuscular adipose tissue content on prognosis in patients undergoing hepatocellular carcinoma resection","volume":"19","author":"Kaibori","year":"2015","journal-title":"J. Gastrointest. Surg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/SLA.0000000000002555","article-title":"Impact of Sarcopenic Obesity on Outcomes in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma","volume":"269","author":"Kobayashi","year":"2019","journal-title":"Ann. Surg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/jgh.13166","article-title":"Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation","volume":"31","author":"Carias","year":"2016","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2169\/internalmedicine.55.5676","article-title":"Sarcopenia and sarcopenic obesity are prognostic factors for overall survival in patients with cirrhosis","volume":"55","author":"Hara","year":"2016","journal-title":"Intern. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"367","DOI":"10.21037\/hbsn.2017.02.02","article-title":"Impact of sarcopenic overweight on the outcomes after living donor liver transplantation","volume":"6","author":"Hammad","year":"2017","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1016\/j.clnu.2018.09.019","article-title":"Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation","volume":"38","author":"Kamo","year":"2019","journal-title":"Clin. Nutr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.hbpd.2018.07.008","article-title":"Impact of body composition on survival and morbidity after liver resection in hepatocellular carcinoma patients","volume":"18","author":"Kroh","year":"2019","journal-title":"Hepatobiliary Pancreat Dis. Int."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/jcsm.12269","article-title":"Association between pre-sarcopenia, sarcopenia, and bone mineral density in patients with chronic hepatitis C","volume":"9","author":"Bering","year":"2018","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Vidot, H., Kline, K., Cheng, R., Finegan, L., Lin, A., Kempler, E., Strasser, S.I., Bowen, D.G., McCaughan, G.W., and Carey, S. (2019). The relationship of obesity, nutritional status and muscle wasting in patients assessed for liver transplantation. Nutrients, 11.","DOI":"10.3390\/nu11092097"},{"key":"ref_30","first-page":"204","article-title":"Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis","volume":"35","author":"Muto","year":"2006","journal-title":"Hepatol. Res"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1073\/pnas.0607312104","article-title":"Critical role of PA28gamma in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis","volume":"104","author":"Moriishi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1053\/j.gastro.2003.11.056","article-title":"Hepatitis C virus infection and diabetes: Direct involvement of the virus in the development of insulin resistance","volume":"126","author":"Shintani","year":"2004","journal-title":"Gastroenterology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.3748\/wjg.v21.i14.4103","article-title":"Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: An open question","volume":"21","author":"Streba","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1530\/JOE-15-0533","article-title":"Insulin resistance and sarcopenia: Mechanistic links between common co-morbidities","volume":"229","author":"Cleasby","year":"2016","journal-title":"J. Endocrinol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/apt.14843","article-title":"Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B","volume":"48","author":"Han","year":"2018","journal-title":"Aliment Pharmacol. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/apt.13889","article-title":"Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"45","author":"Petta","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/hep.28376","article-title":"Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008\u20132011)","volume":"63","author":"Lee","year":"2016","journal-title":"Hepatology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1172\/JCI88881","article-title":"Liver inflammation and fibrosis","volume":"127","author":"Koyama","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/MCO.0b013e328352b4c2","article-title":"Oxidative stress and disuse muscle atrophy: Cause or consequence?","volume":"15","author":"Powers","year":"2012","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jhep.2016.06.007","article-title":"Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: A randomised controlled trial","volume":"65","author":"Sinclair","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"204164","DOI":"10.1155\/2013\/204164","article-title":"Sarcopenic obesity and endocrinal adaptation with age","volume":"2013","author":"Sakuma","year":"2013","journal-title":"Int. J. Endocrinol."},{"key":"ref_42","first-page":"171437","article-title":"TNF-\u03b1 and IFN-s-dependent muscle decay is linked to NF-\u03baB- and STAT-1\u03b1-stimulated Atrogin1 and MuRF1 genes in C2C12 myotubes","volume":"2013","author":"Barbara","year":"2013","journal-title":"Mediators Inflamm."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.diabet.2013.11.004","article-title":"Adiponectin: A multitasking player in the field of liver diseases","volume":"40","author":"Silva","year":"2014","journal-title":"Diabetes Metab."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3748\/wjg.v19.i6.802","article-title":"What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?","volume":"19","author":"Finelli","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s40139-015-0094-y","article-title":"Adiponectin as an anti-fibrotic and anti-inflammatory adipokine in the liver","volume":"3","author":"Park","year":"2015","journal-title":"Curr. Pathobiol. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"286","DOI":"10.5604\/01.3001.0010.8660","article-title":"Clinical significance of serum adiponectin and resistin levels in liver cirrhosis","volume":"17","author":"Correa","year":"2018","journal-title":"Ann. Hepatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"16093","DOI":"10.1038\/s41598-020-73176-z","article-title":"Association between serum irisin concentrations and sarcopenia in patients with liver cirrhosis: A cross-sectional study","volume":"10","author":"Zhao","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cmet.2012.05.012","article-title":"Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling","volume":"16","author":"Imajo","year":"2012","journal-title":"Cell Metabolism"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","article-title":"Inflammatory mechanisms in obesity","volume":"29","author":"Gregor","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e115407","DOI":"10.1371\/journal.pone.0115407","article-title":"Impact of visceral fat on skeletal muscle mass and vice versa in a prospective cohort study: The Korean Sarcopenic Obesity Study (KSOS)","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS ONE"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/hep.29578","article-title":"Visceral adiposity increases risk for hepatocellular carcinoma in male patients with cirrhosis and recurrence after liver transplant","volume":"67","author":"Mazurak","year":"2018","journal-title":"Hepatology"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Sakamaki, A., Yokoyama, K., Koyama, K., Morita, S., Abe, H., Kamimura, K., Takamura, M., and Terai, S. (2020). Obesity and accumulation of subcutaneous adipose tissue are poor prognostic factors in patients with alcoholic liver cirrhosis. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0242582"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Von Hessen, L., Roumet, M., Maurer, M.H., Lange, N., Reeves, H., Dufour, J.F., and Radu, P. (2020). High subcutaneous adipose tissue density correlates negatively with survival in patients with hepatocellular carcinoma. Liver Int.","DOI":"10.1111\/liv.14755"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1007\/s10529-014-1617-z","article-title":"A prepared anti-MSTN polyclonal antibody reverses insulin resistance of diet-induced obese rats via regulation of PI3K\/Akt\/mTOR&FoxO1 signal pathways","volume":"36","author":"Tang","year":"2014","journal-title":"Biotechnol. Lett."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/jcsm.12212","article-title":"Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis","volume":"8","author":"Nishikawa","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2337\/db08-0943","article-title":"Increased secretion and expression of myostatin in skeletal muscle from extremely obese women","volume":"58","author":"Hittel","year":"2009","journal-title":"Diabetes"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/apha.12631","article-title":"Myostatin in relation to physical activity and dysglycaemia and its effect on energy metabolism in human skeletal muscle cells","volume":"217","author":"Hjorth","year":"2016","journal-title":"Acta Physiol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Guo, T., Jou, W., Chanturiya, T., Portas, J., Gavrilova, O., and McPherron, A.C. (2009). Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0004937"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Shabkhiz, F., Khalafi, M., Rosenkranz, S., Karimi, P., and Moghadami, K. (2020). Resistance training attenuates circulating FGF-21 and myostatin and improves insulin resistance in elderly men with and without type 2 diabetes mellitus: A randomised controlled clinical trial. Eur. J. Sport Sci., 1\u201310.","DOI":"10.1080\/17461391.2020.1762755"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/hepr.13543","article-title":"Clinical and anthropometric characteristics of non-obese non-alcoholic fatty liver disease subjects in Japan","volume":"50","author":"Shida","year":"2020","journal-title":"Hepatol. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"18162","DOI":"10.1073\/pnas.1317049110","article-title":"Hyperammonemia in cirrhosis induces transcriptional regulation of myostatin by an NF-kappaB-mediated mechanism","volume":"110","author":"Qiu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3390\/jcm8030336","article-title":"Serum zinc concentration and sarcopenia: A close linkage in chronic liver diseases","volume":"8","author":"Nishikawa","year":"2019","journal-title":"J. Clin. Med."},{"key":"ref_63","first-page":"245","article-title":"Serum insulin like growth factor-1 (IGF-1) and insulin like growth factor binding protein-3 (IGFBP-3) levels in liver cirrhosis","volume":"18","author":"Unsal","year":"2007","journal-title":"Turk. J. Gastroenterol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/MCO.0b013e328337d826","article-title":"Epidemiology of myosteatosis","volume":"13","author":"Miljkovic","year":"2010","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.archger.2013.06.001","article-title":"Myosteatosis and myofibrosis: Relationship with aging, inflammation and insulin resistance","volume":"57","author":"Zoico","year":"2013","journal-title":"Arch. Gerontol. Geriatr."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/aje\/kwv153","article-title":"Age, gene\/environment susceptibility (AGES)-reykjavik study. muscle quality and myosteatosis: Novel associations with mortality risk: The age, gene\/environment susceptibility (AGES)-reykjavik study","volume":"183","author":"Reinders","year":"2016","journal-title":"Am. J. Epidemiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3389\/fphys.2020.00963","article-title":"Myosteatosis in the context of skeletal muscle function deficit: An interdisciplinary workshop at the national institute on aging","volume":"11","author":"Addison","year":"2020","journal-title":"Front. Physiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"110798","DOI":"10.1016\/j.nut.2020.110798","article-title":"Preoperative abnormal body composition is closely related to bacteremia after living donor liver transplantation","volume":"77","author":"Kamo","year":"2020","journal-title":"Nutrition"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000484487","article-title":"preoperative low muscle mass and low muscle quality negatively impact on pulmonary function in patients undergoing hepatectomy for hepatocellular carcinoma","volume":"7","author":"Shirai","year":"2018","journal-title":"Liver Cancer"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12072-018-9875-9","article-title":"Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis","volume":"12","author":"Bhanji","year":"2018","journal-title":"Hepatol. Int."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature13568","article-title":"Alterations of the human gut microbiome in liver cirrhosis","volume":"513","author":"Qin","year":"2014","journal-title":"Nature"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.2147\/DMSO.S249949","article-title":"Serum LPS and CD163 biomarkers confirming the role of gut dysbiosis in overweight patients with NASH","volume":"13","author":"Hegazy","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3462092","DOI":"10.1155\/2018\/3462092","article-title":"Obesity-linked gut microbiome dysbiosis associated with derangements in gut permeability and intestinal cellular homeostasis independent of diet","volume":"2018","author":"Nagpal","year":"2018","journal-title":"J. Diabetes Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s12576-019-00670-z","article-title":"Effects of chronic Porphyromonas gingivalis lipopolysaccharide infusion on skeletal muscles in mice","volume":"69","author":"Kawamura","year":"2019","journal-title":"J. Physiol. Sci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nm.4358","article-title":"Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention","volume":"23","author":"Liu","year":"2017","journal-title":"Nat. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/cid\/ciy205","article-title":"Gut dysbiosis associated with Hepatitis C virus infection","volume":"67","author":"Inoue","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","article-title":"Altered profile of human gut microbiome is associated with cirrhosis and its complications","volume":"60","author":"Bajaj","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.clnu.2009.10.002","article-title":"Short chain fatty acids exchange: Is the cirrhotic, dysfunctional liver still able to clear them?","volume":"29","author":"Bloemen","year":"2010","journal-title":"Clin. Nutr."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/apt.14474","article-title":"Soluble CD163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocation","volume":"47","author":"Rainer","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/iep.12207","article-title":"Inflammation, oxidative stress and apoptosis cascade implications in bisphenol a-induced liver fibrosis in male rats","volume":"97","author":"Elswefy","year":"2016","journal-title":"Int. J. Exp. Pathol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"110639","DOI":"10.1016\/j.exger.2019.110639","article-title":"Gut microbiota and physical frailty through the mediation of sarcopenia","volume":"124","author":"Casati","year":"2019","journal-title":"Exp. Gerontol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"8355","DOI":"10.3748\/wjg.v23.i47.8355","article-title":"Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity","volume":"23","author":"Kaji","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cgh.2011.08.016","article-title":"Prevalence and mechanisms of malnutrition in patients with advanced liver disease, and nutrition management strategies","volume":"10","author":"Cheung","year":"2012","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e2442","DOI":"10.1097\/MD.0000000000002442","article-title":"Factors associated with protein-energy malnutrition in chronic liver disease: Analysis using indirect calorimetry","volume":"95","author":"Nishikawa","year":"2016","journal-title":"Medicine"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/jgh.14665","article-title":"Significant effects of late evening snack on liver functions in patients with liver cirrhosis: A meta-analysis of randomized controlled trials","volume":"34","author":"Chen","year":"2019","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.clnu.2006.01.018","article-title":"ESPEN (European Society for Parenteral and Enteral Nutrition). ESPEN guidelines on enteral nutrition: Liver disease","volume":"25","author":"Plauth","year":"2006","journal-title":"Clin. Nutr."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/hep.26370","article-title":"The nutritional management of hepatic encephalopathy in patients with cirrhosis: International society for hepatic encephalopathy and nitrogen metabolism consensus","volume":"58","author":"Amodio","year":"2013","journal-title":"Hepatology"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1038\/oby.2005.228","article-title":"Obesity in older adults: Technical review and position statement of the American Society for Nutrition and NAASO The Obesity Society","volume":"13","author":"Villareal","year":"2005","journal-title":"Obesity"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1056\/NEJMoa1008234","article-title":"Weight loss, exercise, or both and physical function in obese older adults","volume":"364","author":"Villareal","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Reiner, M., Niermann, C., Jekauc, D., and Woll, A. (2013). Long-term health benefits of physical activity-a systematic review of longitudinal studies. BMC Publ. Health, 13.","DOI":"10.1186\/1471-2458-13-813"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41598-017-18320-y","article-title":"Home exercise training improves exercise capacity in cirrhosis patients: Role of exercise adherence","volume":"8","author":"Kruger","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/lt.24958","article-title":"Exercise and physical activity for patients with end-stage liver disease: Improving functional status and sarcopenia while on the transplant waiting list","volume":"24","author":"Ferrando","year":"2018","journal-title":"Liver Transpl."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Rom\u00e1n, E., Garc\u00eda-Galcer\u00e1n, C., Torrades, T., Herrera, S., Mar\u00edn, A., Do\u00f1ate, M., Alvarado-Tapias, E., Malouf, J., N\u00e1cher, L., and Serra-Grima, R. (2016). Effects of an exercise programme on functional capacity, body composition and risk of falls in patients with cirrhosis: A randomize. Clinical Trial. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0151652"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.cgh.2014.04.016","article-title":"Eight weeks of exercise training increases aerobic capacity and muscle mass and reduces fatigue in patients with cirrhosis","volume":"12","author":"Zenith","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1038\/ctg.2016.38","article-title":"Changes in hepatic venous pressure gradient induced by physical exercise in cirrhosis: Results of a pilot randomized open clinical trial","volume":"7","author":"Torre","year":"2016","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1440-1681.2007.04751.x","article-title":"Exercise performance and ventilatory efficiency in patients with mild and moderate liver cirrhosis","volume":"35","author":"Terziyski","year":"2008","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/hep.24412","article-title":"Branched-chain amino acids as pharmacological nutrients in chronic liver disease","volume":"54","author":"Kawaguchi","year":"2011","journal-title":"Hepatology"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.29107","article-title":"Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasis","volume":"65","author":"Kumar","year":"2017","journal-title":"Hepatology"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/hepr.12774","article-title":"Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria","volume":"46","author":"Nishikawa","year":"2016","journal-title":"Hepatol. Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/4\/1917\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:24:21Z","timestamp":1760160261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/4\/1917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,15]]},"references-count":100,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["ijms22041917"],"URL":"https:\/\/doi.org\/10.3390\/ijms22041917","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,15]]}}}